Jim Simons Aadi Bioscience, Inc. Transaction History
Renaissance Technologies LLC
- $63.1 Billion
- Q3 2024
A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Aadi Bioscience, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 461,822 shares of AADI stock, worth $1 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
461,822
Previous 439,222
5.15%
Holding current value
$1 Million
Previous $641,000
48.36%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding AADI
# of Institutions
62Shares Held
14MCall Options Held
9.4KPut Options Held
2.5K-
Avoro Capital Advisors LLC New York, NY2.85MShares$6.18 Million0.06% of portfolio
-
Bml Capital Management, LLC Zionsville, IN2MShares$4.34 Million2.42% of portfolio
-
Acuta Capital Partners, LLC Belmont, CA1.85MShares$4.01 Million2.91% of portfolio
-
Vanguard Group Inc Valley Forge, PA766KShares$1.66 Million0.0% of portfolio
-
Decheng Capital Management Iii (Cayman), LLC526KShares$1.14 Million1.41% of portfolio
About Aadi Bioscience, Inc.
- Ticker AADI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 21,016,800
- Market Cap $45.6M
- Description
- Aadi Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes. Its lead drug candidate, FYARRO is a form of sirolimus bound to albumin. Aadi is evaluating FYARRO in cancers with known mTOR pathway activation, ...